N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population

N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population

Mark A Babizhayev1, Leslie Burke2, Philip Micans3, Stuart P Richer4,51Innovative Vision Products, Inc., County of New Castle, Delaware, USA; 2Wise Choice Products LLC, London, England, United Kingdom; 3IAS Group, Sark, United Kingdom; 4Eye Clinic DVA Medical Center, North Chicago, Illinois, USA; 5De...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mark A Babizhayev, Leslie Burke, Philip Micans, Stuart P Richer
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
age-related ophthalmic diseases
cataract
disability-glare
halos
Halometer
visual-acuity
N-acetylcarnosine lubricant eye drops
repurchase behavior analysis
50000-patients’ compliance to self-administer eye drops
Geriatrics
RC952-954.6
Acceso en línea:https://doaj.org/article/6efa6d7812914e16a005c86b5b78bb27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/6efa6d7812914e16a005c86b5b78bb27

Ejemplares similares